Chronic Kidney Disease Trends and Forecast
The future of the global chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets. The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chronic Kidney Disease by Segment
The study includes a forecast for the global chronic kidney disease by treatment, end use, and region.Chronic Kidney Disease Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
- Drugs
- Dialysis
Chronic Kidney Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospital
- Dialysis Center
- Others
Chronic Kidney Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Chronic Kidney Disease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic kidney disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic kidney disease companies profiled in this report include-- Baxter International
- Teva Pharmaceutical Industries
- AstraZeneca
- Johnson & Johnson
- AbbVie
- Becton
- Dickinson and Company
- B. Braun
- F. Hoffmann-La Roche
- Pfizer
Chronic Kidney Disease Market Insights
The publisher forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.Within this market, hospitals is expected to witness the higher growth as it is equipped with advanced facilities, which are required to treat and manage CKD
APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.Features of the Global Chronic Kidney Disease Market
- Market Size Estimates: Chronic kidney disease market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Chronic kidney disease market size by treatment, end use, and region in terms of value ($B).
- Regional Analysis: Chronic kidney disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different treatments, end uses, and regions for the chronic kidney disease market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic kidney disease market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the chronic kidney disease market size?Answer: The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030.
Q2. What is the growth forecast for chronic kidney disease market?
Answer: The global chronic kidney disease market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the chronic kidney disease market?
Answer: The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.
Q4. What are the major segments for chronic kidney disease market?
Answer: The future of the chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets.
Q5. Who are the key chronic kidney disease market companies?
Answer: Some of the key chronic kidney disease companies are as follows:
- Baxter International
- Teva Pharmaceutical Industries
- AstraZeneca
- Johnson & Johnson
- AbbVie
- Becton
- Dickinson and Company
- B. Braun
- F. Hoffmann-La Roche
- Pfizer
Answer: The publisher forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.
Q7. In chronic kidney disease market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the chronic kidney disease market by treatment (drugs and dialysis), end use (hospital, dialysis center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Chronic Kidney Disease Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International
- Teva Pharmaceutical Industries
- AstraZeneca
- Johnson & Johnson
- AbbVie
- Becton
- Dickinson and Company
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
